SCHEMBL31542050

SCHEMBL31542050

CC(C)n1c(Cc2ccc(C(=O)NO)cc2)nc2ccccc2c1=O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC6 Q9UBN7 12/20 0.53
HDAC8 Q9BY41 6/20 0.53
HDAC1 Q13547 6/20 0.53
HDAC11 Q96DB2 4/20 0.53
HDAC2 Q92769 1/20 0.52
CYP3A4 P08684 1/20 0.48
CYP2C9 P11712 1/20 0.48
CYP2C19 P33261 1/20 0.48
KCNH2 Q12809 1/20 0.48
ALDH1A1 P00352 3/20 0.46
KDM4E B2RXH2 1/20 0.46
HPGD P15428 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
HDAC3 O15379 1/20 0.46
NPC1 O15118 1/20 0.45
RAB9A P51151 1/20 0.45
MT-CO1 P00395 1/20 0.45
MT-CO2 P00403 1/20 0.45
KMT2A Q03164 2/20 0.45
MEN1 O00255 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31542057 0.85 HDAC6 (0.60) HDAC6HDAC8HDAC1HDAC11HDAC2
SCHEMBL31542070 0.83 HDAC6 (0.62) HDAC6HDAC8HDAC1HDAC11HDAC2
SCHEMBL31542055 0.82 NPC1 (0.70) HDAC6HDAC8HDAC1HDAC11HDAC2
SCHEMBL31542049 0.80 NPC1 (0.51) HDAC6HDAC8HDAC1HDAC11HDAC2
SCHEMBL31542054 0.79 HDAC6 (0.50) HDAC6HDAC8HDAC1HDAC11HDAC2
SCHEMBL31542075 0.78 HDAC6 (0.53) HDAC6HDAC8HDAC1HDAC11HDAC2
SCHEMBL31542064 0.78 ALDH1A1 (0.61) HDAC6HDAC8HDAC1HDAC11HDAC2
SCHEMBL31542068 0.78 ALDH1A1 (0.58) HDAC6HDAC8HDAC1HDAC11HDAC2
SCHEMBL31542069 0.77 ALDH1A1 (0.75) HDAC1CYP3A4CYP2C9CYP2C19ALDH1A1
SCHEMBL9728402 0.76 RAB9A (0.57) ALDH1A1KDM4ESMN1; SMN2NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4622964-A1 QUINAZOLINONE DERIVATIVES FOR HDAC INHIBITION Gilva Therapeutics Co., Ltd. (TW) 2025-10-01 EP claimed
WO-2025085669-A1 QUINAZOLINONE DERIVATIVES FOR HDAC INHIBITION GILVA THERAPEUTICS CO., LTD. (CN) 2025-04-24 WO claimed
EP-4622964-A1 QUINAZOLINONE DERIVATIVES FOR HDAC INHIBITION Gilva Therapeutics Co., Ltd. (TW) 2025-10-01 EP disclosed
WO-2025085669-A1 QUINAZOLINONE DERIVATIVES FOR HDAC INHIBITION GILVA THERAPEUTICS CO., LTD. (CN) 2025-04-24 WO disclosed